Towa Pharmaceutical Future Growth
Future criteria checks 1/6
Towa Pharmaceutical is forecast to grow earnings and revenue by 1.9% and 4.2% per annum respectively. EPS is expected to grow by 5.7% per annum. Return on equity is forecast to be 9.4% in 3 years.
Key information
1.9%
Earnings growth rate
5.7%
EPS growth rate
Pharmaceuticals earnings growth | 12.6% |
Revenue growth rate | 4.2% |
Future return on equity | 9.4% |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 275,200 | 14,825 | 12,371 | N/A | 2 |
3/31/2026 | 261,816 | 12,903 | 9,671 | N/A | 5 |
3/31/2025 | 245,836 | 11,658 | -4,205 | N/A | 5 |
3/31/2024 | 229,894 | 12,715 | -16,716 | N/A | 5 |
12/31/2023 | 236,779 | 11,735 | N/A | N/A | N/A |
9/30/2023 | 225,755 | 6,462 | -41,269 | -270 | N/A |
6/30/2023 | 218,035 | 5,556 | N/A | N/A | N/A |
3/31/2023 | 208,859 | 2,201 | -27,910 | 2,544 | N/A |
12/31/2022 | 180,407 | 2,898 | N/A | N/A | N/A |
9/30/2022 | 173,861 | 9,364 | -7,723 | 6,118 | N/A |
6/30/2022 | 168,060 | 11,998 | N/A | N/A | N/A |
3/31/2022 | 165,615 | 15,914 | 8,636 | 22,129 | N/A |
12/31/2021 | 165,262 | 19,511 | N/A | N/A | N/A |
9/30/2021 | 162,514 | 16,949 | 8,472 | 20,785 | N/A |
6/30/2021 | 159,927 | 15,934 | N/A | N/A | N/A |
3/31/2021 | 154,900 | 13,958 | 2,370 | 12,008 | N/A |
12/31/2020 | 141,230 | 12,981 | N/A | N/A | N/A |
9/30/2020 | 129,674 | 13,688 | 6,515 | 13,171 | N/A |
6/30/2020 | 119,878 | 14,074 | N/A | N/A | N/A |
3/31/2020 | 110,384 | 14,503 | 14,494 | 19,164 | N/A |
12/31/2019 | 111,218 | 13,989 | N/A | N/A | N/A |
9/30/2019 | 111,315 | 14,364 | 16,026 | 22,234 | N/A |
6/30/2019 | 108,016 | 13,673 | N/A | N/A | N/A |
3/31/2019 | 105,104 | 13,475 | 7,648 | 19,002 | N/A |
12/31/2018 | 101,309 | 9,577 | N/A | N/A | N/A |
9/30/2018 | 97,871 | 8,369 | 7,703 | 19,755 | N/A |
6/30/2018 | 96,411 | 8,056 | N/A | N/A | N/A |
3/31/2018 | 93,430 | 6,495 | 3,857 | 19,230 | N/A |
12/31/2017 | 91,660 | 8,145 | N/A | N/A | N/A |
9/30/2017 | 89,126 | 9,794 | N/A | 11,457 | N/A |
6/30/2017 | 87,285 | 8,680 | N/A | N/A | N/A |
3/31/2017 | 84,949 | 5,576 | N/A | 10,195 | N/A |
12/31/2016 | 84,582 | 6,180 | N/A | N/A | N/A |
9/30/2016 | 83,474 | 3,755 | N/A | 11,304 | N/A |
6/30/2016 | 82,862 | 4,345 | N/A | N/A | N/A |
3/31/2016 | 82,115 | 7,684 | N/A | 3,732 | N/A |
12/31/2015 | 79,649 | 8,521 | N/A | N/A | N/A |
9/30/2015 | 77,164 | 11,064 | N/A | 3,621 | N/A |
6/30/2015 | 74,414 | 12,076 | N/A | N/A | N/A |
3/31/2015 | 71,470 | 11,118 | N/A | 8,037 | N/A |
12/31/2014 | 69,181 | 9,758 | N/A | N/A | N/A |
9/30/2014 | 66,260 | 8,041 | N/A | 8,836 | N/A |
6/30/2014 | 63,232 | 6,075 | N/A | N/A | N/A |
3/31/2014 | 61,351 | 5,992 | N/A | 8,144 | N/A |
12/31/2013 | 58,762 | 6,342 | N/A | N/A | N/A |
9/30/2013 | 57,058 | 5,510 | N/A | 6,800 | N/A |
6/30/2013 | 56,091 | 6,033 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4553's forecast earnings growth (1.9% per year) is above the savings rate (0.2%).
Earnings vs Market: 4553's earnings (1.9% per year) are forecast to grow slower than the JP market (9.4% per year).
High Growth Earnings: 4553's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4553's revenue (4.2% per year) is forecast to grow slower than the JP market (4.4% per year).
High Growth Revenue: 4553's revenue (4.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4553's Return on Equity is forecast to be low in 3 years time (9.4%).